The syndrome of inappropriate secretion of antidiuretic hormone (SIADH) is a clinical state in which the secretion of antidiuretic hormone (ADH), also called arginine vasopressin (AVP), is not suppressed appropriately when plasma osmolality falls below the osmotic threshold and may lead to impaired renal water excretion, increased total body water, and hyponatremia. 1) SIADH is associated with a number of underlying clinical conditions, such as malignancy, lung disease, and central nervous system and hormonal disorders.
2)AVP is a peptide hormone that is released from the posterior pituitary gland in response to an increase in plasma osmolality and volume depletion. Three classes of specific receptor have been identified in the periphery. The vasopressin V 1A receptor, which has been identified in vascular smooth muscle cells, hepatocytes and platelets, and the vasopressin V 1B receptor, which is found predominantly in the anterior pituitary, are coupled to the phosphoinositide pathway and elevation of intracellular Ca 2ϩ . The vasopressin V 2 receptor, which is located in the kidney and the vascular endothelium, is coupled to the adenylate cyclase pathway, causing an increase in c-AMP.3) AVP elicits a potent water reabsorption effect in the collecting ducts of the kidney via the vasopressin V 2 receptors, as well as systemic vasoconstriction via the vasopressin V 1A receptors. [4][5][6] The facilitation of renal water reabsorption via the vasopressin V 2 receptor results in an increase in total body water, which in turn causes a decrease in blood sodium concentration and plasma osmolality. The increased total body water causes inhibition of sodium reabsorption in the proximal tubule via inhibition of the renin-angiotensin-aldosterone system, as well as elevation of glomerular filtration rate and facilitation of the secretion of atrial natriuretic peptide (ANP) from the atrium.7) These stimuli produce sustained urinary sodium excretion, and result in hyponatremia, the most common electrolyte disorder associated with SIADH. Clinical manifestations of hyponatremia range from mild symptoms, such as headache, nausea, and vomiting, to severe symptoms, such as disorientation, disturbed consciousness and seizures. 8) Although the treatment of hyponatremia should be directed at the primary underlying etiology of disorder, this is not always entirely possible. Thus, the general approach to the management of hyponatremia is normalization of blood sodium concentration by the prevention of water retention in the body.
9)One treatment used for acute severe hyponatremia is the intravenous administration of furosemide concomitantly with hypertonic saline. Diuretics are used in the treatment of chronic hyponatremia, however, resistance to loop diuretics such as furosemide is a common problem in hyponatremia patients.10) Further, loop diuretics may worsen hyponatremia and induce hypokalemia, a potentially serious electrolyte disorder that can result in the prolongation of QT interval and the subsequent risk of ventricular arrhyt...